45.25
+2.84%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sagittarius Life Science
Its shares trade on Taipei Exchange under the ticker 3205.TWO. It has been listed since 28 May 2004. In the fiscal year to 31 December 2025, it reported revenue of TWD 346.1m and a net loss of TWD 49.6m. At that date it held total assets of TWD 1.07bn and shareholders' equity of TWD 1.04bn.
Sagittarius Life Science Corp. engages in the manufacture, research and development, and sale of Chinese and western medicine. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-05-28. The firm's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The firm also provides related technical services for the research and development of Chinese and western pharmaceutical products. The firm distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 28 May 2004
- Employees
- 24
- Website
- naturalbiokey.com ↗
Leadership
Pay as last reported
- Lewei ChenChairman of the Board, since 2024
- Ms. Baohui HuangVice Chairman of the Board, since 2009TWD 3.4m
- Wanyu ZhangChief Financial Officer, Head of Finance & Accounting, Corporate Governance Officer
- Mr. Junheng ChenGeneral Manager, Director, since 2020
- Ms. Pei-Wen ChenDirector
- Wensen LuoDirector
- Lianchun QiuDirector, since 2003
- Zhongchi LinIndependent Director
- Jinglun YuIndependent Director
- Jianneng ZhongIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sagittarius Life Science Corp manufactures Chinese and western medicine in Taipei City with 24 employees.
- The company's main products include nutrition formulations and natural organic food for domestic and Asian markets.
- Sagittarius Life Science Corp provides technical services for R&D of Chinese and western pharmaceutical products.
Weaknesses
- The company has only 24 employees, which may limit its operational capacity.
- Sagittarius Life Science Corp's domestic market focus may restrict international growth opportunities.
- Limited product range compared to larger competitors in the Consumer Staples sector.
Opportunities
- Expanding into the Americas market for health formulations and natural food products.
- Growing demand for natural and organic food in Asian markets like Taipei City.
- Increasing global interest in Chinese herbal medicines and plant new medicines.
Threats
- Competition from larger pharmaceutical firms in the Consumer Staples sector.
- Regulatory challenges in the Asian and American markets for health products.
- Economic downturns affecting consumer spending on health and beauty care.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.